INTRODUCTION
Obsessive-compulsive disorder (OCD) is characterized by repetitive, irrational, and intrusive thoughts and compulsions, resulting in significant socio-occupational dysfunction. While there are several treatment options available, the mainstay treatment has been psychopharmacological approach in the form of serotonin-reuptake inhibitors or psychotherapy in the form of cognitive behavior therapy or both. [1] Despite adequate treatment, nearly 40% of patients do not respond to either treatment, warranting need for developing newer treatment strategies. [2] Furthermore, invasive treatment studies have shown the involvement of prefrontal-cortical regions in the neurobiological basis of OCD. Indeed, structural and functional changes corresponding to the regions subserving the CSTC circuits explain the neurobiological alterations seen in OCD. [6] In this review, we describe and discuss various studies that have examined the effects of repetitive TMS (rTMS) and transcranial direct current stimulation (tDCS) in alleviating the symptoms in OCD patients.
REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION IN OBSESSIVE-COMPULSIVE DISORDER
rTMS is a noninvasive brain stimulation technique used in various neuropsychiatric conditions. rTMS uses low-intensity magnetic field to stimulate specific brain areas by inducing neurophysiologic changes. Low-frequency stimulation, i.e., <5 Hz, leads to decreased neuronal activity while high-frequency stimulation, i.e., >10 Hz, increases neuronal activity. [7] A recent modification to this technique in the form of deep TMS seems to allow stimulation of deeper and larger brain structures as compared to conventional rTMS. In this section, we review the evidence of rTMS utilization in OCD around specific areas of stimulation.
SUPPLEMENTARY MOTOR AREA
There is evidence that suggests reduced cortico-subcortical inhibition and cortical hyperexcitability result in the repetitive behavior associated with OCD. [8] An open-label study by Mantovani et al., 2006 [9] had shown initially that low-frequency rTMS over supplementary motor area (SMA) had led to significant improvement of OC symptoms in 10 patients with comorbid Tourette syndrome. This improvement in clinical symptoms had correlated with improved resting-state cortical motor threshold and also sustained up to 3 months follow-up. Later, a double-blind, randomized controlled trial (RCT) from the same study group in 18 patients with resistant OCD showed greater reduction of symptoms in active stimulation compared to sham stimulation. [10] However, this was not statistically significant (P = 0.154). In another RCT with 22 patients with resistant OCD, low-frequency active rTMS treatment significantly reduced the symptoms score and this improvement remained stable at 12 weeks of follow-up compared to sham rTMS. [11] However, an RCT from France, in 40 patients with resistant OCD, failed to demonstrate significant difference between active and sham low-frequency stimulation of SMA. [12] An open-label case series observation, from India, in 17 patients with resistant OCD, had shown that low-frequency rTMS is less likely to produce improvement in severely ill patients. [13] Another open-label study from India had shown significant improvement in 12 patients with treatment-refractory OCD over 15 sessions of low-frequency rTMS. [14] However, an RCT from our center involving 36 patients with refractory OCD failed to demonstrate any significant difference between active and sham low-frequency rTMS over bilateral pre-SMA. [15] A pilot open-label trial had shown significant reduction of OCD in two-third of patients treated with rTMS for 3 weeks who had not previously responded to antidepressant trial. [16] In a recent open-label study from Korea, 4 weeks of low-frequency TMS over SMA did not produce any significant change in OCD symptoms. [17] A 6-week, multisite RCT had shown clinically significant reduction in symptoms in patients with refractory OCD. [18] The symptom reduction achieved at the end of 6 weeks remained stable for further 6 weeks. The studies conducted using rTMS over pre-SMA/ SMA is shown in Table 1 .
DORSOLATERAL PREFRONTAL CORTEX
Dorsolateral prefrontal cortex (DLPFC) exerts control over multiple subcortical structures that are clinically relevant for attention, concentration, and executive functions. Dysfunction in DLPFC and related circuits had been implicated in various symptom dimensions of OCD.
Right dorsolateral prefrontal cortex
High-frequency 20 Hz single-session stimulation in 12 patients, with each patient randomized to receive over right/left DLPFC or mid-occipital regions, had shown that only after right DLPFC stimulation, compulsive urges reduced significantly and the effect lasted about 8 h after stimulation. [19] One of the earliest sham-controlled RCT reported that low-frequency 1 Hz stimulation over right DLPFC, three sessions per week for 6 weeks, was ineffective in producing any significant change in patients with OCD. [20] In an open-label study, adjunctive high-frequency rTMS to the right DLPFC did not show any significant change of obstetric cholestasis (OC) symptoms in 42 patients. However, both depression and anxiety scores reduced significantly. [21] In 30 treatment-resistant OCD patients, high-frequency 10 Hz stimulation over right DLPFC consisting of 30 sessions failed to show any significant difference between active and sham condition. [22] Forty-five patients randomized to three arms to receive low-frequency 1 Hz versus high-frequency 10 Hz versus sham stimulation over right DLPFC had concluded that only 1 Hz stimulation had significantly reduced symptoms. [23] A 3-week RCT, comparing active versus sham stimulations of low-frequency 1 Hz stimulation over right DLPFC reported superiority of active simulation over sham in relieving OCD symptoms. [24] Left dorsolateral prefrontal cortex A sham-controlled double-blind study suggested that 2 weeks of high-frequency rTMS over left DLPFC was ineffective in bringing any change in Yale-Brown OC scale (YBOCS) scores. However, when extended for 4 weeks, active stimulation reduced OC symptoms significantly but not after controlling for change in depression scores. [25] A novel study from Egypt had attempted application of high-frequency 20 Hz over left DLPFC with 15 sessions as monotherapy in 20 drug-free patients with OCD. However, there was no significant change between active and sham stimulation. In the same study, when high-frequency stimulation was applied as an add-on to antidepressant medication over left DLPFC, it led to significant reduction in symptoms. [26] Low-frequency 1 Hz rTMS applied over left DLPFC as an add-on to medications in 30 patients did not show any significant change between active and sham stimulation. [27] Bilateral dorsolateral prefrontal cortex Electroencephalography-guided, frequency-balanced, bilateral DLPFC stimulation over 10 sessions using a sham-controlled design in 46 OCD patients had shown significant reduction of obsessions and anxiety symptoms in active stimulation compared to sham stimulation. [28] A single-blind RCT with intra-individual cross-over design using bilateral high-frequency 20 Hz DLPFC stimulation reported significant reduction of symptoms with active stimulation. Both responders and partial responders were observed only in true condition in this study. [29] Another intra-individual sham-controlled study, involving high frequency over bilateral DLPFC had reported significant reduction in symptoms as well as cognitive performance after true stimulation condition. [30] This same study group also replicated the finding on efficacy of bilateral DLPFC high-frequency 20 Hz stimulation in improving symptoms but not cognitive function. [31] Further, sequential administration of low-frequency 1 Hz stimulation over DLPFC and SMA did not produce any significant change in symptoms. [32] The key rTMS studies with DLPFC as the target region are summarized in Table 2 .
ORBITOFRONTAL CORTEX
Neuroimaging studies suggest hyper-excitability of orbitofrontal cortex (OFC) along with other cortical/ subcortical structures in the pathophysiology of OCD. A retrospective study from India had suggested that there is a role of applying low-frequency 1 Hz to inhibit this hyper-excitable state of left OFC and ameliorating symptoms. [33] A double-blind RCT study that involved the administration of low-frequency rTMS over right OFC demonstrated significant reduction of symptoms in addition to reduction of metabolism in bilateral OFC in Open-label pilot study n=10
Low-frequency 1 Hz, 100% RMT, 20 min, one session per day, 10 sessions over 2 weeks
Significant reduction in YBOCS, HAM-D, HAM-A. Improvement persisted at 3 months follow-up Mantovani et al., 2010 [10] RCT n=21
Low-frequency 1 Hz, 100% RMT, 5 min, 20 min, one session per day, 20 sessions over 4 weeks No significant difference between active and sham at the end of 4 weeks Gomes et al., 2012 [11] RCT n=22
Significant reduction of YBOCS scores in active group (15. 3 points) versus sham (5.3 points). Improvement persisted at 3 months follow-up Pelissolo et al., 2016 [12] RCT n=40
Low-frequency 1 Hz, 100% RMT, 5 min, 20 min, one session per day, 20 sessions over 4 weeks Neuronavigation assisted
No significant difference between active and sham at the end of 4 weeks Response rates were 10.5% in active versus 20% in sham group Hegde et al., 2016 [13] Case series n=17
Low-frequency 1 Hz, 100% RMT, 5 min, 20 min, one session per day, 18 sessions over 3 weeks Only 2 patients showed more than 25% reduction in YBOCS scores Kumar and Chadda 2011 [14] Opel label n=12
Low-frequency 1 Hz, 100% RMT, 10 sessions over 2 weeks
Mean YBOCS scores reduced significantly from 26.17 to 17.17 Arumugham et al., 2018 [15] RCT n=40
Low-frequency 1 Hz, 100% RMT, 5 min, 20 min, one session per day, 18 sessions over 3 weeks No significant difference between 2 groups in reduction of YBOCS scores or response rates Pallanti et al., 2016 [16] Open-label n=50 25 add-on rTMS versus 25 add-on antipsychotics Low-frequency 1 Hz, 100% RMT, 5 min, 20 min, one session per day, 15 sessions over 3 weeks
2/3 of patients in TMS responded versus 1/4 of patients in antipsychotic group
Lee et al., 2017 [17] Open-label n=9
Low-frequency 1 Hz, 100% RMT, 5 min, 20 min, one session per day, 20 sessions over 4 weeks Reduction of compulsion contributed to the total YBOCS reduction, but there was no significant reduction in obsessions cores Hawken et al., 2016 [18] Multisite RCT n=22
Low-frequency 1 Hz, 100% RMT, 5 min, 20 min, one session per day, 30 sessions over 6 weeks
Significant reduction of YBOCS scores in active versus sham group. The effect maintained at 6 weeks follow-up. 80% response rate in active versus 8% in sham group HAM-A -Hamilton Anxiety Rating Scale; HAM-D-Hamilton Depression Rating Scale; RCT -Randomized controlled trial; RMT -Resting motor threshold; rTMS -Repetitive transcranial magnetic stimulation; YBOCS -Yale-Brown Obsessive-Compulsive Scale positron emission tomography. [34] Another study conducted on 23 medication-resistant OCD patients that applied low-frequency rTMS over left OFC for 15 days reported significant reduction in symptoms in true condition that lasted till 10 weeks but not 12 weeks. [35] The key rTMS studies with OFC as the target region are summarized in Table 3 .
Summary
Only studies that administered inhibitory rTMS over OFC had reported consistently positive effects on symptom reduction. However, those studies are few in number and sample size, also proven negative when compared against other areas in a meta-analysis. [36] Studies involving SMA and DLPFC areas had reported mixed results and all the findings from those studies are limited by small sample 
RCT

Single session n=12
High-frequency 20 Hz, 80% RMT, single session, 20 min, randomized to receive stimulation over L-DLPFC, R-DLPFC, and midoccipital regions
Significant reduction of compulsive urges was noted only after right-DLPFC stimulation which lasted up to 8 h Alonso et al., 2001 [20] RCT n=18
Low-frequency 1 Hz, 110% RMT, 20 min, 3 sessions per week, 18 sessions over right-DLPFC No significant difference between true and sham groups Sarkhel et al., 2010 [21] Single-blind trial n=42
High-frequency 10 Hz, 110% RMT, 20 min, 10 sessions in 2 weeks over right-DLPFC No significant difference between true and sham groups Mansur et al., 2011 [22] RCT n=30
High-frequency 10 Hz, 110% RMT, 20 min, 30 sessions in 5 weeks over R-LPFC and followed up for 6 weeks Active rTMS does not appear to be superior to sham Elbeh et al., 2016 [23] RCT n=45
Three groups 1 Hz versus 10 Hz versus sham, 100% RMT, 10 sessions in 2 weeks over right-DLPFC and followed up for 3 months 1 Hz was more effective than 10 Hz and sham stimulation Seo et al., 2016 [24] RCT n=27
Low-frequency 1 Hz, 100% RMT, 20 min, 15 sessions in 3 weeks, over right-DLPFC Mean YBOCS reduced significantly in active (10.7) versus sham (3.7) Sachdev et al., 2007 [25] RCT n=18
High-frequency 10 Hz, 110% RMT, 20 min, 10 sessions in 2 weeks over left-DLPFC Both groups did not differ significantly Badawy et al. 2010 [26] a. RCT in drug-naïve patients as monotherapy [27] RCT n=33
Low-frequency 1 Hz, 110% RMT, 20 min, 10 sessions in 2 weeks over left-DLPFC followed further for 2 more weeks Both groups did not differ significantly Ma et al., 2014 [28] RCT n=46
Electroencephalogram guided 8-12 Hz alpha band stimulation, 80% RMT, 20 min, 10 sessions in 2 weeks over bilateral DLPFC and followed for further 1 week
Significant reduction of both obsessions and anxiety scores
Haghighi et al., 2015 [29] RCT n=21
High-frequency 20 Hz, 100% RMT, 50 min, 10 sessions in 2 weeks over bilateral-DLPFC Intra-individual 2 weeks true and 2 weeks sham balanced As compared to sham, active treatment significantly improved both in expert rated and self-rated scales Jahangard et al., 2016 [30] RCT n=10
High-frequency 20 Hz, 100% RMT, 50 min, 10 sessions in 2 weeks over bilateral-DLPFC Intra-individual 2 weeks true and 2 weeks sham balanced Obsessions reduced significantly. Simultaneously cognitive performance improved Shayganfard et al., 2016 [31] RCT n=10
High-frequency 20 Hz, 100% RMT, 50 min, 10 sessions in 2 weeks over bilateral-DLPFC Intra-individual 2 weeks true and 2 weeks sham balanced
Obsessions reduced significantly. But cognitive performance did not improve Kang et al., 2009 [32] RCT n=20 Retrospective study n=25
Low-frequency 1 Hz, 110% RMT, 30 min, 20 sessions in 4 weeks over OFC Significant reduction in symptoms which did not remain till 1-month follow-up Nauczyciel et al., 2014 [34] RCT n=19
Low-frequency 1 Hz, 120% RMT, 20 min, 10 sessions in 1 week over OFC. Crossover design with 1 month washout period No significant difference between active and sham group Ruffini et al., 2009 [35] RCT n=23
Low-frequency 1 Hz, 80% RMT, 10 min, 15 sessions in 3 weeks over OFC. With a follow-up of 12 weeks Significant reduction in symptoms in active group that lasted for10 weeks but not 12 weeks OFC -Orbitofrontal cortex; RCT -Randomized controlled trial; RMT -Resting motor threshold; rTMS -Repetitive transcranial magnetic stimulation sizes. Various researchers had attempted pooling data from the above studies to overcome this limitation by conducting meta-analyses. All five meta-analyses [36] [37] [38] [39] [40] had uniformly suggested that there is definite benefit of add-on true rTMS in patients with resistant OCD. Zhou et al., 2017 [36] had suggested that low-frequency/high-frequency stimulation of SMA area and DLPFC area is beneficial with overall largest effect size of g = 0.71 (SMA g = 0.56; left DLPFC g = 0.47; right DLPFC g = 0.93). Most of the studies had been conducted on resistant OCD patients and for a shorter duration of time ranging from 1 to maximum 12 weeks. Large, multicenter trials in both resistant and nonresistant OCD patients are the need of the hour. Along with application of electroencephalograph/perfusion imaging in guiding specific target areas and stimulation parameters might advance our understanding about variations in efficacy and eventually to overcome the limitations.
TRANSCRANIAL ELECTRIC CURRENT STIMULATION
tECS is a technique involving application of small-intensity electric current on the scalp using specialized devices. tECS is mainly of two types, transcranial alternating current stimulation (tACS) and tDCS. tACS involves application of alternating current at various frequencies, whereas tDCS involves application of direct current which is constant over time. tDCS has been widely studied and used more often in the treatment of psychiatric disorders.
TRANSCRANIAL DIRECT CURRENT STIMULATION IN OBSESSIVE-COMPULSIVE DISORDER
tDCS is a re-emergent noninvasive brain stimulation technique that has shown promise in alleviating symptoms in various neuropsychiatric disorders. Most of the studies pertaining to application of tDCS in psychiatric disorders have been done in patients with depression and schizophrenia. Only a handful of studies have been done in OCD and related disorders. Volpato et al., 2013 [41] probably described the first application of tDCS in an OCD patient. This was a single case study with active and sham tDCS cross-over. The stimulation montage involved cathodal stimulation of left DLPFC, with a primary aim of comparing the effect of tDCS and rTMS on resting-state brain activity. The study reported no change observed in OC symptoms, whereas improvement in depression was noted after true tDCS. Following this, there have been 11 studies that are published looking at the beneficial effects of tDCS in OCD and one study employing tACS. The current review focuses on studies involving transcranial electric current stimulation in OCD with a detailed discussion on tDCS.
The primary focus of all the studies has been symptom improvement as measured by changes in YBOCS scores and improvement in affective symptoms such as anxiety and depression. Only one study has looked at cognitive improvement following tDCS. [42] All the studies published so far have reported improvement in OC symptoms to a varying extent. However, all these studies are either single case study or case series or open-label study designs. There has not been a single study employing randomized sham-controlled double-blind design. Only one study by D'Urso et al., 2016 [42] employed a randomized, controlled double-blind partial cross-over design but without a sham arm. A randomized double-blind sham-controlled study (Gowda et al., unpublished) from our center examined the efficacy of anodal tDCS to preSMA in OCD. Twenty five patients were randomly allocated into "verum" and "sham" arms and 2 mA of current was applied for 5 days (10 sessions). The response rate was significantly greater in the verum tDCS (4 out of 12) compared to sham tDCS. Given the limitations in the study design and sample size, these results are to be interpreted cautiously. Moreover, positive reports of a new treatment approach could be due to publication bias. The details of these studies are summarized in Table 4 .
Despite the limitations of these studies, there are certain factors that make tDCS treatment unique and attractive. One of the most important factors among them is the magnitude of response. Studies described in Table 4 report varying levels of improvement ranging from 15% reduction in YBOCS scores to as high as 80%. The magnitude of response is important here mainly because most of the studies reported have applied tDCS in treatment-refractory patients. Next important factor is the persistence of treatment response after tDCS treatment. Longitudinal studies report a minimum of 1 month to a maximum of 7 months sustenance of effects. One of the most interesting observations of tDCS treatment in OCD is the rapidity with which tDCS brings about changes in OCD. All the studies reported have applied tDCS for 5 days (10 sessions) to a maximum of few weeks with a good clinical improvement. In addition, tDCS has demonstrated a favorable adverse effect profile and is one of the most common observations in most tDCS studies, irrespective of the disorder. The minimal side effects reported in any study are mild tingling and burning sensation which was well tolerated by all the participants. However, long-term safety is yet to be established. Despite all the unique features mentioned above, one has to remember that these features require systematic testing and reproducibility in larger samples.
TRANSCRANIAL DIRECT CURRENT STIMULATION PROTOCOLS IN OBSESSIVE-COMPULSIVE DISORDER
Almost all the studies in OCD have utilized conventional tECS device which delivers current using a pair of conductive rubber electrodes wrapped in sponge pouches soaked in saline. tECS involves the application of weak electric current [44] Case series of two cases Anodal stimulation of left pre-SMA/SMA; cathode was placed over right supraorbital area 2 mA of current for 20 min, twice a day with a 3 h interval on 5 consecutive days >40% reduction in YBOCS score along with improvement in anxiety and depressive symptoms Study of two cases. Medication change during or just before tDCS is not mentioned Bation et al., 2016 [45] Open-label pilot study of 8 cases
The cathode was placed over the left OFC and the anode was placed over the right cerebellum 3 cm below the inion and 1 cm right from the midline Mean YBOCS total score reduced by 26% immediately after 10 sessions and lasted for 3 months
Open-label study design Hazari et al., 2016 [46] Single case study Anodal stimulation of left pre-SMA/SMA; cathode was placed over right supraorbital area 2 mA of current for 20 min, twice a day with a 3 h interval for 10 days Open-label study design in the range of 1-2 mA over specified brain regions in an attempt to modulate them. [54] The stimulus is delivered using electrodes of various sizes placed over designated areas of interest on the scalp, which is one of the crucial factors determining the outcomes of tDCS. Depending on the polarity of the stimulus, the brain region underneath the electrode gets stimulated or inhibited (anode stimulates and cathode inhibits the underlying area). However, the stimulation/inhibition is not site limited. In addition to site of stimulation, the other important parameters that can affect the outcome of tDCS are the current density, duration of stimulation, and size of the electrodes the details of which are beyond the scope of this review.
Site of stimulation can be considered as one of the most crucial parameters determining the outcome of tDCS. This is entirely dependent on the target disorder or target symptom. The neural substrates of psychiatric disorders are still inconclusive. Various studies aiming at elucidating the same have implicated many neural systems in the pathophysiology of OCD. However, given the complexity of the disorder as well as the brain and its circuitry, there is no one single neural substrate that can act as a switch for OCD symptom generation. Several multimodal neuroimaging studies have demonstrated aberrant activities (hypo-or hyper-activity) in brain regions comprising the orbitofrontal-striato-pallido-thalamic network, including orbitofrontal cortex (OFC), DLPFC, cingulate cortex, SMA, caudate and thalamus, and limbic system. [55, 56] All the studies of noninvasive neuromodulation involving both tDCS and TMS have mainly focused on modulating the orbitofronto-striato-pallido-thalamic network, which has been critically implicated in the neurobiology of OCD. [4] 
MECHANISM OF ACTION OF TRANSCRANIAL DIRECT CURRENT STIMULATION IN OBSESSIVE-COMPULSIVE DISORDER
Given the heterogeneity associated with the networks as well as symptoms in OCD, several rTMS studies have targeted mostly SMA, OFC, or medial prefrontal cortex for ameliorating OC symptoms, whereas few studies have targeted DLPFC with the hope of alleviating comorbid affective symptoms in OCD. [4] Taking cues from these rTMS studies and the evidence from the circuit dysfunction theories in OCD, tDCS studies have mainly focused on OFC and SMA/pre-SMA and two studies focusing on DLPFC modulation [ Table 4 ]. We discuss the mechanism of action of tDCS along the lines of site of stimulation.
DORSOLATERAL PREFRONTAL CORTEX
Three studies in OCD have targeted DLPFC with varying electrode montages. In the first study by Volpato et al., 2013 , [41] the cathode was placed on the left DLPFC and anode was placed extracephalically at the posterior part of the neck using 35 cm 2 sponge electrodes. This study reported no change in OC symptoms, while there was a significant decrease in anxiety and depression scores following tDCS. This was based on the earlier evidence of decreased functional connectivity in the default-mode network, anterior cingulate gyrus (ACC), middle frontal gyrus, and putamen in OCD patients. [57] The authors concluded that the cathodal stimulation probably increased the functional activity in the rostral part of ACC and the midline OFC with simultaneous reduction in the asymmetry of activation between right and left DLPFC. Palm et al., 2017 [51] targeted bilateral DLPFC with anode over the left DLPFC and cathode over the right DLPFC using 35 cm 2 sponge electrodes. The authors based their strategy on the evidence from studies on the effect of tDCS on cognition in healthy controls and patients with depression. DLPFC being the major hub of cognitive, behavioral, control might also have a significant influence on other connected networks. The authors hypothesized that the DLPFC stimulation using tDCS might modulate the cognitive control over obsessions and compulsions, simultaneously targeting the comorbid affective symptoms. Yet, another study by Dinn et al., 2016 [50] also placed anode over left DLPFC, while placing cathode over right OFC. However, cathodal OFC was the active electrode and left DLPFC anodal stimulation in this study was mainly targeting the executive dysfunction and affective symptoms than the OC symptoms.
ORBITOFRONTAL CORTEX
Functional neuroanatomical studies have assigned a critical role to the OFC in manifestation of OC symptoms.
Studies have also proposed that specific areas of the OFC contribute to reward-guided learning and decision-making. Hyperactivity of these areas within the OFC has been proposed to attribute anticipatory affective value to future 
Author
Study design tDCS method and stimulation parameters Key findings Limitations
Klimke et al., 2016 [53] An open-label study of tACS in 7 patients 3 cm × 4 cm electrodes placed at bilateral frontotemporal sites 650 µA of alternating current at a frequency of 40 Hz for 20 min thrice a week for a total duration ranging from 2-7 weeks
52% reduction in mean YBOCS scores
Open-label study design with nonuniform total stimulation duration tDCS -Transcranial direct current stimulation; DLPFC -Dorsolateral prefrontal cortex; SMA -Supplementary motor area; YBOCS -Yale-Brown Obsessive-Compulsive Scale; OFC -Orbitofrontal cortex events, resulting in rumination about future aversive events. [58, 59] Several neuroimaging studies have reported hyperactivity in OFC during symptom provocation tasks and also during resting state. [60, 61] In fact, the hyperactivity was one of the predictors of treatment response since it showed a direct correlation with symptom severity. [62] Overall five studies have used OFC as the target site of stimulation in tDCS for OCD. The first study using this montage was by Mondino et al., 2015 , [43] wherein cathodal stimulation of left OFC was done using 35 cm 2 sponge electrode and anodal electrode of 100 cm 2 was placed over the occipital cortex. This was based on the earlier reports of improvement in OC symptoms following low-frequency rTMS applied over OFC with a subsequent observation of decrease in OFC activity. [34, 35] In their study, Mondino et al., 2015 found a 26% reduction in OC symptoms after 1 month of tDCS, attributing the effects to decrease in OFC activity following cathodal stimulation. Along the same lines, Alizadeh Goradel et al., 2016 [48] in their single case study reported 64% improvement in OC symptoms and near-total improvement in anxiety and depression following cathodal stimulation of OFC.
Bation et al., 2016 [45] in an open-label pilot study design of eight patients placed cathode over left OFC and anode over right cerebellum. This was based on the evidence of hypoactivity of cerebellum and its role in OCD as reported by meta-analysis of several functional and structural neuroimaging studies. [63, 64] Further, neuroimaging studies have also demonstrated aberrant interconnections between orbitofronto-striato-pallido-thalamic loop and cerebellum in OCD patients, which could be critical in the generation of OC symptoms or the cognitive correlates of OCD. [ The largest open-label study of tDCS in OCD comprising 42 patients by Najafi et al., 2017 [52] also used cathodal stimulation of OFC (right) with anode placed over the area covering left pareito-temporo-occipital regions. This study reported nearly 63% improvement in OC symptoms following 3 weeks of tDCS treatment, along with the persistence of improvement for 3 months.
PRE-SUPPLEMENTARY MOTOR AREA/ SUPPLEMENTARY MOTOR AREA
Pre-SMA/SMA has been implicated in OCD pathogenesis as much as the OFC. As discussed earlier in the TMS section, there is evidence that suggests reduced cortico-subcortical inhibition and cortical hyperexcitability resulting in the repetitive behavior associated with OCD. However, there is contradicting evidence of hypoactivity at pre-SMA, contributing to lack of inhibition of striatal function resulting in hyperactivity of striatum, giving rise to OC symptoms. [67] Based on this evidence, one of the first studies to target pre-SMA/SMA was a case report by [44] The authors based their hypothesis on the theory of deficient response inhibition in OCD, the function attributed to pre-SMA/SMA. [68, 69] In view of this theory, the authors placed anode over left pre-SMA/SMA and cathode over the right supraorbital area. The study results reported >40% reduction in YBOCS score along with improvement in anxiety and depressive symptoms. The authors hypothesized that the clinical improvement could be due to increase in the left SMA activity after anodal tDCS improving the response inhibition. Subsequently, the same group reported a significant improvement (80%) in episodic OCD following anodal tDCS to pre-SMA. This study also reported long-term sustenance of improvement and significant benefits following booster tDCS, 7 months after relapse. [46] Subsequent to these, there were two studies targeting pre-SMA/SMA in OCD. Both studies from the same group applied cathodal tDCS to pre-SMA/SMA in a single case report study with a significant improvement following tDCS. [47] The second study involved placing either the anode/cathode electrode on bilateral pre-SMA depending on the cross-over design in 12 patients. The results of this study demonstrated superiority of cathodal stimulation of pre-SMA over anode. Another study by Silva et al. [49] followed the same montage of cathodal stimulation of bilateral pre-SMA with good improvement in clinical symptoms.
Summary
TMS studies that administered inhibitory rTMS over OFC had reported consistently positive effects on symptom reduction. However, those studies are few in number and sample size was less when compared against other areas in a meta-analysis. [36] Studies involving SMA and DLPFC areas had reported mixed results, and all the findings from those studies are limited by small sample sizes. Various researchers had attempted pooling data from the above studies to overcome this limitation by conducting meta-analyses. All five meta-analyses [36] [37] [38] [39] [40] had uniformly suggested that there is definite benefit of add-on true rTMS in patients with resistant OCD. Recent studies [36, 39] had suggested that low-frequency/high-frequency stimulation of SMA area and DLPFC area are beneficial. Most of the studies had been conducted on resistant OCD patients and for a shorter duration of time ranging from 1 to maximum 12 weeks.
In case of tDCS, the studies are very few when compared to TMS and the studies published so far are very preliminary.
Most of these studies are case reports/case series and open-label study designs with lesser evidential value compared to RCTs. In addition, similar to TMS, tDCS studies have also tried to explore their way into modulating the best neural correlates of OC symptoms. As a result, studies have mainly explored the beneficial effects of tDCS-induced modulation of either OFC or pre-SMA/SMA. All these studies have reported significant benefit suggesting OFC and pre-SMA/SMA as the ideal targets. DLPFC stimulation as explored by two studies mainly contributes to improvement in comorbid affective symptoms rather than OC symptoms. In addition to lack of systematic study design, these studies have employed varying stimulation parameters such as duration of stimulation, intensity of current, inter-stimulus interval, and electrode sizes, suggesting prematurity of these findings.
CONCLUSIONS
Pressing need of the hour is to establish further support with large trials in both resistant and nonresistant OCD patients, more so in case of tDCS where there is a serious lack of systematic studies. In addition to evaluating the persistence of improvement induced by both rTMS and tDCS, longitudinal studies are essential to establish long term safety of these techniques. In addition, systematic study designs coupled with multimodal investigative tools exploring the neuroimaging measures and electrophysiological measures might advance our understanding about variations in treatment response and mechanism of action of noninvasive brain stimulation techniques. 
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